The Supreme Court has ruled that the Federal Trade Commission (FTC) does not have authority under Section 13(b) of the FTC Act to seek disgorgement or restitution from defendants. The agency has increasingly relied on this...more
The U.S. Federal Trade Commission (FTC) recently settled enforcement actions against four companies accused of misleading consumers about their participation in the European Union-United States Privacy Shield framework, which...more
10/11/2018
/ Consent Order ,
Enforcement Actions ,
EU-US Privacy Shield ,
Federal Trade Commission (FTC) ,
FTC Act ,
International Data Transfers ,
Misleading Statements ,
Privacy Laws ,
Registration Requirement ,
Section 5 ,
Self-Certification ,
U.S. Commerce Department ,
Unfair or Deceptive Trade Practices
In a closely watched data-security case, the U.S. Court of Appeals for the Eleventh Circuit vacated as unenforceable a cease and desist order issued by the U.S. Federal Trade Commission (FTC) against LabMD, Inc. According to...more
6/12/2018
/ Administrative Appeals ,
Administrative Law Judge (ALJ) ,
Appeals ,
Cease and Desist Orders ,
Data Breach ,
Data Security ,
Due Process ,
Enforcement Actions ,
Federal Trade Commission (FTC) ,
FTC Act ,
Invasion of Privacy ,
LabMD ,
Lack of Specificity ,
Personally Identifiable Information ,
Popular ,
Reversal ,
Section 5 ,
Unfair or Deceptive Trade Practices ,
Vacated
The U.S. Federal Trade Commission (FTC) recently settled enforcement actions against three companies accused of misleading consumers about their participation in the European Union-United States Privacy Shield framework,...more
9/12/2017
/ Corporate Counsel ,
Cross-Border Transactions ,
Enforcement Actions ,
EU-US Privacy Shield ,
Federal Trade Commission (FTC) ,
Fraud ,
International Data Transfers ,
Misrepresentation ,
Personally Identifiable Information ,
Self-Certification ,
Swiss Privacy Shield
The U.S. Federal Trade Commission (FTC) recently announced a settlement resolving its competitive concerns over the merger of two leading generic drug manufacturers – Teva and Allergan. In July 2015, Teva agreed to acquire...more
8/1/2016
/ Abbreviated New Drug Application (ANDA) ,
Actavis Inc. ,
Divestiture ,
Enforcement Actions ,
Federal Trade Commission (FTC) ,
Generic Drugs ,
Manufacturers ,
Mergers ,
Pharmaceutical Industry ,
Settlement ,
Teva Pharmaceuticals
Key Points:
The FTC is raising the maximum civil penalty that may be imposed for certain violations from $16,000 to $40,000.
For HSR Act violations, where penalties may be imposed for each day the person is in...more
7/1/2016
/ Antitrust Violations ,
Civil Monetary Penalty ,
Compliance ,
Department of Justice (DOJ) ,
Enforcement Actions ,
Federal Civil Penalties Inflation Adjustment Act Improvements Act of 2015 ,
Federal Trade Commission (FTC) ,
FTC Act ,
Hart-Scott-Rodino Act ,
Mergers ,
Premerger Notifications ,
Reporting Requirements ,
Threshold Requirements ,
Unfair or Deceptive Trade Practices